Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Value Added Technology Co., Ltd. (043150.KQ)
KRW17,470.00
-350.00 (-1.96%)
KR KOE Healthcare Medical - Specialties
Address
37, Gwahaksaneop 2-ro 20beon-gil, Jillye-myeon 50877
Hwaseong-si, KR
Hwaseong-si, KR
CEO
Seon-Beom Kim
Website
bhi.co.kr
IPO
2006-09-29
ISIN KR7043150002
Description
Value Added Technology Co., Ltd. engages in the development, manufacture, and sale of dental imaging equipment. It offers digital X-rays, computed tomography machines, generators, oral sensors, and other diagnostic equipment. The company was founded on April 4, 1992 and is headquartered in Hwaseong-si, South Korea.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW17,470.00
-350.00 (-1.96%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
33.2K
Beta
0.48
Float Shares
6.91M
Free Float %
46.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.13% | -3.78% | -6.28% | +3.34% | +2.85% | +10.07% | +5.61% | -41.33% | -35.47% | -45.26% | +140.56% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
17,470.00
DCF (Unlevered)
50,060.01
+186.5%
DCF (Levered)
59,811.49
+242.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.55
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%+10.7% ★ Q1'26: +3.8% (vs Q1'25)
-
EPS growth Medical - Specialties: +10.1%-27.2% Q1'26: +17.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%+9.1% ★ Q1'26: +22.9% (vs Q1'25)
-
EBIT margin Medical - Specialties: +12.6%+12.9% ★ Q1'26: +10.5% (vs Q1'25)
-
ROIC Medical - Specialties: +6.6%+9.6% ★ Q1'26: +7.7% (vs Q1'25)
-
Share dilution Medical - Specialties: 0.0%-2.6% ★ Q1'26: -1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×0.62× ★ Q1'26: 1.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 1 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
217.36B
est: 218.27B (-0.4%)
|
178.56B
est: 239.04B (-25.3%)
|
218.81B
est: 218.99B (-0.1%)
|
234.39B
est: 230.56B (+1.7%)
|
271.70B
est: 271.85B (-0.1%)
|
244.31B
est: 244.58B (-0.1%)
|
338.98B
est: 337.50B (+0.4%)
|
395.06B
est: 394.95B (+0.0%)
|
384.95B
est: 385.75B (-0.2%)
|
385.19B
est: 382.80B (+0.6%)
|
426.42B
est: 419.17B (+1.7%)
|
452.75B
444.77B – 466.67B
+8.0% YoY
|
493.20B
429.24B – 530.96B
+8.9% YoY
|
528.00B
488.49B – 556.58B
+7.1% YoY
|
| EBITDA |
45.99B
est: 38.13B (+20.6%)
|
35.74B
est: 41.75B (-14.4%)
|
42.54B
est: 38.25B (+11.2%)
|
46.93B
est: 40.27B (+16.5%)
|
53.01B
est: 47.48B (+11.6%)
|
-10.18B
est: 42.72B (-123.8%)
|
81.11B
est: 58.95B (+37.6%)
|
95.73B
est: 68.98B (+38.8%)
|
83.87B
est: 67.38B (+24.5%)
|
83.02B
est: 82.92B (+0.1%)
|
71.65B
est: 90.79B (-21.1%)
|
98.07B
96.34B – 101.08B
+8.0% YoY
|
106.83B
92.97B – 115.01B
+8.9% YoY
|
114.37B
105.81B – 120.56B
+7.1% YoY
|
| EBIT |
37.69B
est: 30.27B (+24.5%)
|
29.93B
est: 33.15B (-9.7%)
|
35.47B
est: 30.37B (+16.8%)
|
42.22B
est: 31.98B (+32.0%)
|
49.87B
est: 37.70B (+32.3%)
|
-21.02B
est: 33.92B (-162.0%)
|
71.25B
est: 46.81B (+52.2%)
|
84.16B
est: 54.77B (+53.6%)
|
69.26B
est: 53.50B (+29.5%)
|
67.93B
est: 69.51B (-2.3%)
|
54.78B
est: 76.11B (-28.0%)
|
82.21B
80.76B – 84.74B
+8.0% YoY
|
89.56B
77.94B – 96.41B
+8.9% YoY
|
95.88B
88.70B – 101.07B
+7.1% YoY
|
| Net Income |
21.29B
est: 23.65B (-10.0%)
|
24.77B
est: 23.89B (+3.7%)
|
79.09B
est: 85.08B (-7.0%)
|
27.26B
est: 31.53B (-13.5%)
|
33.88B
est: 34.28B (-1.1%)
|
-24.22B
est: -13.31B (-82.0%)
|
51.24B
est: 59.02B (-13.2%)
|
76.89B
est: 71.67B (+7.3%)
|
51.73B
est: 67.65B (-23.5%)
|
55.13B
est: 51.40B (+7.3%)
|
40.13B
est: 42.38B (-5.3%)
|
49.71B
48.46B – 50.83B
+17.3% YoY
|
55.02B
41.17B – 63.05B
+10.7% YoY
|
52.21B
47.13B – 55.88B
-5.1% YoY
|
| SGA |
51.13B
est: 27.28B (+87.4%)
|
41.22B
est: 29.88B (+38.0%)
|
59.91B
est: 27.37B (+118.9%)
|
65.65B
est: 28.82B (+127.8%)
|
32.02B
est: 33.98B (-5.8%)
|
26.59B
est: 30.57B (-13.0%)
|
34.76B
est: 42.18B (-17.6%)
|
49.82B
est: 49.36B (+0.9%)
|
55.29B
est: 48.21B (+14.7%)
|
55.40B
est: 49.97B (+10.9%)
|
58.25B
est: 54.72B (+6.5%)
|
59.10B
58.06B – 60.92B
+8.0% YoY
|
64.38B
56.03B – 69.31B
+8.9% YoY
|
68.92B
63.77B – 72.65B
+7.1% YoY
|
| EPS |
1,433.31
est: 1,591.90 (-10.0%)
|
1,667.28
est: 1,608.52 (+3.7%)
|
5,324.29
est: 5,728.07 (-7.0%)
|
1,835.08
est: 2,122.68 (-13.5%)
|
2,280.94
est: 2,307.50 (-1.2%)
|
-1,630.47
est: -896.00 (-82.0%)
|
3,449.20
est: 3,973.67 (-13.2%)
|
5,176.32
est: 4,824.75 (+7.3%)
|
3,482.80
est: 4,554.50 (-23.5%)
|
3,711.77
est: 3,551.00 (+4.5%)
|
2,740.35
est: 2,928.00 (-6.4%)
|
3,434.50
3,348.23 – 3,512.14
+17.3% YoY
|
3,801.00
2,844.16 – 4,356.34
+10.7% YoY
|
3,607.00
3,256.11 – 3,860.84
-5.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-04 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-29 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
71.28B
OE per share TTM
4,871.85
Owner's Yield
21.54%
Maintenance CapEx ratio
30.88%
Maint CapEx / Avg PPE
29.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
175.01M
Shares Outstanding
14.85M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sang-Wook Ahn | Chief Executive Officer, Senior Managing Director and Director | — | male |
| Seung-Ho Kang | MD, Head of Management Strategy Division & Inside Director | — | male |
| Tae-Woo Kim | MD, Research Director & Inside Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 043150.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
